Computational identification of surface markers for isolating distinct subpopulations from heterogeneous cancer cell populations
The study developed clusterCleaver, a computational package that uses statistical-distance metrics on single-cell RNA sequencing data to identify candidate surface markers that are maximally unique to transcriptomic subpopulations within heterogeneous cancer cell lines for potential FACS isolation. The authors applied and experimentally validated the workflow in the MDA-MB-231 and MDA-MB-436 breast cancer cell lines, experimentally confirming ESAM and BST2/tetherin as surface markers that identify and separate major transcriptomic subpopulations in those lines, respectively. A key caveat is that the experimental validation was performed in specific breast cancer cell line models rather than across broader tumor contexts, and the approach targets transcriptomic subpopulations observable by scRNA-seq. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
1,509 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00